UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

____________

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

October 20, 2006

 

___________________________________________________________

 

IGI, INC.

(Exact Name of Registrant as Specified in Charter)

 

___________________________________________________________

 

Delaware

001-08568

01-0355758

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(I.R.S. Employer
Identification Number)

     

105 Lincoln Avenue

Bunea, New Jersey 08310

(Address of Principal Executive Offices) (Zip Code)

 

(856) 697-1441

(Registrant's Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ]

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

[  ]

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

[  ]

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))

     

[  ]

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))

<PAGE>  

Item 8.01

Other Events

   

      On October 20, 2006 the Company issued a press release regarding an Agreement with DermWorx, Inc, which is attached as Exhibit 99.1.

   

Item 9.01

Financial Statements and Exhibits

 

Exhibit Number

 

Description

     

99.1

 

Press Release dated October 20, 2006 announcing Agreement with DermWorx, Inc.

<PAGE>  

SIGNATURES

 

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 

IGI, INC.

   
 

By:

/s/ Frank Gerardi

   


   

Frank Gerardi

   

Chairman & Chief Executive Officer

     

Date:  October 25, 2006

   

<PAGE>  

Exhibit Index

 

Exhibit Number

Description

   

99.1

Press Release dated October 20, 2006 announcing Agreement with DermWorx, Inc.

<PAGE>